Skip to main content

Table 1 Clinical baseline characteristics of healthy controls and patients with sepsis

From: LncRNA CYP1B1-AS1 as a clinical biomarker exacerbates sepsis inflammatory response via targeting miR- 18a- 5p

Parameters

Controls

(n = 92)

Sepsis patients

(n = 116)

P value

Demographics

 Age (years), mean ± SD

55.77 ± 9.02

53.76 ± 8.48

0.101

 BMI (kg/m2), mean ± SD

23.73 ± 4.25

24.26 ± 4.17

0.365

 Male, n (%)

45 (48.91)

68 (58.62)

0.207

 Smoke, n (%)

40 (43.48)

54 (46.55)

0.676

 Drink, n (%)

41 (44.57)

57 (49.14)

0.576

Medical history, n (%)

 Hypertension

31 (33.70)

46 (39.67)

0.390

 Hyperlipidemia

37 (40.22)

39 (33.61)

0.385

 Diabetes

32 (34.78)

47 (40.52)

0.472

Biochemical indicators, median (IQR)

 Scr (mg/dL)

0.85 (0.72, 1.01)

1.60 (1.16, 2.05)

< 0.001

 Albumin (g/L)

44.76 (39.42, 51.63)

32.42 (25.64, 38.31)

< 0.001

 WBC (× 109/L)

5.92 (5.07, 6.85)

18.37 (15.25, 22.67)

< 0.001

 CRP (mg/L)

4.95 (3.96, 6.93)

106.47 (79.91, 136.31)

< 0.001

Disease severity, mean ± SD

 SOFA score

 

7.00 (4.00, 9.00)

-

 APACHE II score

 

18.50 (14.00, 23.00)

-

Inflammatory cytokine, median (IQR)

 TNF-α (pg/mL)

29.70 (23.76, 36.63)

199.00 (150.98, 250.47)

< 0.001

 IL- 6 (pg/mL)

13.12 (9.90, 18.12)

51.48 (37.62, 72.27)

< 0.001

 IL- 8 (pg/mL)

15.35 (12.87, 20.79)

112.34 (81.51, 142.51)

< 0.001

 IL- 1β (pg/mL)

25.25 (19.31, 32.18)

182.16 (137.12, 216.32)

< 0.001

  1. Abbreviations: BMI Body mass index, Scr Serum creatinine, WBC White blood cell, CRP C-reactive protein, SOFA Sequential organ failure assessment, APACHE II Acute physiology and chronic health evaluation II, IL Interleukin, TNF Tumor necrosis factor, SD Standard deviation, IQR Interquartile range